Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:50 AM
Ignite Modification Date:
2025-12-25 @ 2:50 AM
NCT ID:
NCT01815333
Eligibility Criteria:
Inclusion Criteria:
1. Enrolled at MDACC, Written consent
2. Measurable nodes on the recent cross sectional imaging (CT, MRI. US) or suspicious lymph nodes for metastasis
3. Requiring tissue diagnosis (FNA, core biopsy, surgical biopsy, surgical resection), or clinical follow-ups for at least 6 months.
4. Any and all primary disease sites in the abdomen and pelvis will be allowed
Exclusion Criteria:
1. Primary or secondary iron overload
2. Lactation or pregnant - women of child bearing potential will be excluded
3. Contraindications for MRI
4. Contraindication or allergy to Feraheme® (based on insert)
5. Clinically documented or risk of primary or secondary iron overloading (e.g. History of thalassemia, sickle cell anemia, hereditary hemochromatosis, multiple transfusions with any reason), anemia not caused by iron deficiency
6. Age under 18
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01815333
Study Brief:
Protocol Section:
NCT01815333